logo

For the Inventor, By the Inventor

Salt Lake City, UT, United States of America

Min Zhang

This inventor holds 5 USPTO granted patents. Top assignee: University of Utah Research Foundation. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Zhang. Retrieved from https://idiyas.com/inventor/min-zhang-2wqvy5ui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 60.0

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:

goldMedal5 out of 1,687 
 
University of Utah Research Foundation
 patents

Years Active: 2016-2025

Loading Chart...
5 patents (USPTO):Explore Patents
1. 12286422 - Methods and compositions of 4-substituted benzoylpiperazine-1-substituted carbonyls as β-catenin/B-cell lymphoma 9 inhibitors (2025-04-29),
2. 11542254 - Methods and composition of 4-substituted benzoylpiperazine-1-substituted carbonyls as beta-catenin/B-cell lymphoma 9 inhibitors (2023-01-03),
3. 10273246 - Methods and compositions of substituted 5H-[1,2,5] oxadiazolo [3',4′:5,6] pyrazino[2,3-B] indole analogs as inhibitors of β-catenin/T-cell factor protein-protein interactions (2019-04-30),
4. 9738628 - Substituted 1H-indazol-1-OL analogs as inhibitors of beta catenin/Tcf protein-protein interactions (2017-08-22),
5. 9284299 - Substituted 1H-indazol-1-ol analogs as inhibitors of beta catenin/Tcf protein-protein interactions (2016-03-15),

Title: Min Zhang: Innovator in Cancer Treatment

Introduction

Min Zhang is a prominent inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific protein interactions associated with various cancers. With a total of 5 patents to his name, Zhang's work is paving the way for innovative treatments.

Latest Patents

One of Zhang's latest patents focuses on "Methods and compositions of 4-substituted benzoylpiperazine-1-substituted carbonyls as β-catenin/B-cell lymphoma 9 inhibitors." This invention relates to compounds that have a specific structure and their derivatives. The patent outlines synthetic methods for creating these compounds, as well as pharmaceutical compositions that include them. The methods described aim to treat disorders, including various tumors and cancers, that are linked to dysfunctions in β-catenin/BCL9 protein-protein interactions.

Career Highlights

Min Zhang is affiliated with the University of Utah Research Foundation, where he conducts his research and development work. His innovative approach to drug development has garnered attention in the scientific community, contributing to advancements in cancer treatment.

Collaborations

Zhang collaborates with notable colleagues, including Haitao Ji and Binxun Yu. Their combined expertise enhances the research efforts at the University of Utah Research Foundation, fostering an environment of innovation and discovery.

Conclusion

Min Zhang's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight the importance of innovative research in addressing complex medical challenges. His work continues to inspire advancements in therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…